Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation

Area of Science:

• Molecular Biology
• Signal Transduction
• Drug Discovery

Background:

• Signal transducer and activator of transcription (STAT) factors are crucial transcription factors.
• Current inhibitors primarily target STAT tyrosine phosphorylation or SH2 domains.
• STATs possess six conserved domains involved in essential protein-protein interactions.

Purpose of the Study:

• To explore alternative rational approaches for developing STAT modulators.
• To highlight the potential of targeting protein-protein interactions within STAT domains.
• To expand strategies beyond traditional inhibition sites for JAK-STAT signaling modulation.

Main Methods:

• Focus on rational drug design targeting conserved STAT domains.
• Utilizing N-terminal domains as a case study for inhibitor development.
• Investigating protein-protein interactions as druggable targets.

Main Results:

• Identified protein-protein interactions as promising targets for STAT modulation.
• Demonstrated the potential of targeting conserved domains beyond phosphorylation sites.
• Proposed alternative rational approaches for developing novel JAK-STAT signaling modulators.

Conclusions:

• Targeting STAT protein-protein interactions offers a viable strategy for drug discovery.
• Alternative approaches to STAT inhibition can yield novel chemical biology tools.
• Modulating JAK-STAT signaling through novel interactions presents therapeutic opportunities.